Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02471352 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 years later Jan 31, 2027 → Jan 31, 2035
See other at-risk trials from National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Record History

The 50 most recent of 198 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Eligibility criteria expanded, about 9 words
    • Study description expanded, about 5 words
  3. 3 versions Re-verified since Aug 26, 2026, no change to tracked fieldsv194-v196
  4. Primary and study completion pushed from Jan 31, 2027 to Jan 31, 2035v193
  5. 7 versions Re-verified since Dec 31, 2025, no change to tracked fieldsv186-v192
Show 37 earlier versionsHide 37 earlier versions
  1. Study Status, Contacts/Locationsv185
  2. 18 versions Re-verified since Mar 22, 2025, no change to tracked fieldsv167-v184
  3. Eligibility criteria shortened, about 3 wordsv166
  4. Eligibility criteria expanded, about 4 wordsv165
  5. 13 versions Re-verified since Jan 30, 2024, no change to tracked fieldsv152-v164
  6. Enrollment target: 500 to 700v151
  7. Re-verified, no change to tracked fieldsv150
  8. Study Status, Eligibilityv149
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: \- Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them. Objectives: \- To determine the causes of various skin diseases and find ways to treat them. Eligibility: * People ages 2 and older who have: * A skin disease or at risk of developing a skin disease OR * A family member of persons with a skin disease * Healthy volunteers ages 2 and older Design: * Participants will be screened under a separate protocol. * Participants may take a survey about how their skin condition affects their quality of life. * Participants will have a medical history and a physical exam including a detailed skin exam. Pictures will be taken of their skin to document any skin disease. * Participants will have specimens collected. This may include: * Several teaspoons of blood taken at each visit * Stool samples * Nail and body fluid (like saliva) samples * Cheek swabs. The inside of the cheek will be scraped for about a minute in each direction to collect cells. * Collection of skin samples with: * A swab (like a Q-tip) * Gently scraping skin to remove the outer layers of cells * Applying and removing 1-inch pieces of tape * Participants may have up to 4 skin biopsies in 12 months, with 4 separate biopsies taken each time. * An area of skin will be numbed with an injection. * A piece of skin the size of a pencil eraser will be removed using a small instrument. * A flat scar usually develops at the biopsy site.
Trial Details
NCT Number NCT02471352
Lead Sponsor National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions
(from sponsor)		 Dermatologic Conditions, Healthy Volunteers, Normal Volunteers, Carcinoma, Merkel Cell
Related terms Carcinoma, Merkel Cell, Skin Diseases
Enrollment 700 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov